Bioadvise ApS: Financial statements 2024
CVR: 39920034
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Bioadvise ApS (CVR 39920034) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -10,620 and a net result of DKK -210,600 compared with DKK -28,944 the year before. Equity in the 2024 report amounted to DKK -34,634.
- Gross Profit
- DKK -10,620
- Profit/Loss
- DKK -210,600
- Equity
- DKK -34,634
- Total Assets
- DKK 7,603
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -11 t. | -211 t. | -35 t. | 0 |
| 2023 | - | 0 | -29 t. | 176 t. | 0 |
| 2022 | - | -154 t. | -176 t. | 205 t. | 0 |
| 2021 | - | 122 t. | 53 t. | 381 t. | 0 |
| 2020 | - | 448 t. | 91 t. | 289 t. | 1 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Bioadvise ApS has published its annual report for 2023. Gross profit came to DKK 0, and the net result was DKK -28,944.
About Bioadvise ApS
Bioadvise ApS was a Danish company of the type Anpartsselskab based in Kongens Lyngby, founded in 2018. The company has been dissolved on 21 September 2026. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Bioadvise IVS. The company has 1 employee (2020). In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK -210,600 the year before. Equity in the 2025 report amounted to DKK -34,634.